These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31731456)

  • 21. Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors.
    Kopkova A; Sana J; Machackova T; Vecera M; Radova L; Trachtova K; Vybihal V; Smrcka M; Kazda T; Slaby O; Fadrus P
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31614872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pathology of primary central nervous system lymphoma in HIV-positive patients-a 41 Chinese patients retrospective study.
    Chen J; Sun L; Dai Y; Zhang L; Yang K; Han X; Ding X; Gao H; Zhou X; Wang P
    Ann Diagn Pathol; 2023 Apr; 63():152108. PubMed ID: 36638601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy.
    Balikov DA; Hu K; Liu CJ; Betz BL; Chinnaiyan AM; Devisetty LV; Venneti S; Tomlins SA; Cani AK; Rao RC
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma.
    Heming M; Haessner S; Wolbert J; Lu IN; Li X; Brokinkel B; Müther M; Holling M; Stummer W; Thomas C; Schulte-Mecklenbeck A; de Faria F; Stoeckius M; Hailfinger S; Lenz G; Kerl K; Wiendl H; Meyer Zu Hörste G; Grauer OM
    Genome Med; 2022 Sep; 14(1):109. PubMed ID: 36153593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput quantitation of amino acids and acylcarnitine in cerebrospinal fluid: identification of PCNSL biomarkers and potential metabolic messengers.
    Ma J; Chen K; Ding Y; Li X; Tang Q; Jin B; Luo RY; Thyparambil S; Han Z; Chou CJ; Zhou A; Schilling J; Lin Z; Ma Y; Li Q; Zhang M; Sylvester KG; Nagpal S; McElhinney DB; Ling XB; Chen B
    Front Mol Biosci; 2023; 10():1257079. PubMed ID: 38028545
    [No Abstract]   [Full Text] [Related]  

  • 26. Circulating microRNAs in Cerebrospinal Fluid and Plasma: Sensitive Tool for Detection of Secondary CNS Involvement, Monitoring of Therapy and Prediction of CNS Relapse in Aggressive B-NHL Lymphomas.
    Krsmanovic P; Mocikova H; Chramostova K; Klanova M; Trnkova M; Pesta M; Laslo P; Pytlik R; Stopka T; Trneny M; Pospisil V
    Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
    Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
    Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Tim-1 in primary CNS lymphoma.
    Kishimoto W; Nishikori M; Arima H; Miyoshi H; Sasaki Y; Kitawaki T; Shirakawa K; Kato T; Imaizumi Y; Ishikawa T; Ohno H; Haga H; Ohshima K; Takaori-Kondo A
    Cancer Med; 2016 Nov; 5(11):3235-3245. PubMed ID: 27709813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA Biomarkers in Canine Diffuse Large B-Cell Lymphoma.
    Elshafie NO; Nascimento NCD; Lichti NI; Kasinski AL; Childress MO; Santos APD
    Vet Pathol; 2021 Jan; 58(1):34-41. PubMed ID: 33287683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micro RNAs as a Diagnostic Marker between Glioma and Primary CNS Lymphoma: A Systematic Review.
    Dabbagh Ohadi MA; Aleyasin MS; Samiee R; Bordbar S; Maroufi SF; Bayan N; Hanaei S; Smith TR
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular diagnostics for vitreoretinal lymphoma].
    Bonzheim I; Salmerón-Villalobos J; Süsskind D; Szurman P; Gekeler F; Spitzer MS; Salaverria I; Campo E; Coupland SE; Quintanilla-Martinez L; Fend F
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):150-154. PubMed ID: 37947807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key Histomorphologic, Immunophenotypic, and Genetic Features.
    Lauw MIS; Lucas CG; Ohgami RS; Wen KW
    Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33322508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.
    Cirera S; Andersen-Ranberg EU; Langkilde S; Aaquist M; Gredal H
    Acta Vet Scand; 2019 Dec; 61(1):57. PubMed ID: 31796072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma.
    Ungureanu A; Le Garff-Tavernier M; Costopoulos M; Parratte T; Brinet A; Durand H; Gaultier C; Hurstel R; Alamome I; Sellal F; Ahle G
    J Neurol; 2021 Aug; 268(8):2890-2894. PubMed ID: 33609156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Level of IL-10 in Cerebrospinal Fluid is Specific for Diagnosis of Primary Central Nervous System Lymphoma.
    Shao J; Chen K; Li Q; Ma J; Ma Y; Lin Z; Kang H; Chen B
    Cancer Manag Res; 2020; 12():6261-6268. PubMed ID: 32801871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients.
    Yuan WX; Gui YX; Na WN; Chao J; Yang X
    Oncol Lett; 2016 Jan; 11(1):423-432. PubMed ID: 26870228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of digital PCR for MYD88
    Chen K; Ma Y; Ding T; Zhang X; Chen B; Guan M
    Exp Ther Med; 2020 Jul; 20(1):301-308. PubMed ID: 32536998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
    Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient.
    DeRon N; Ahmed M; Lopez D; Alobaidi A
    Cureus; 2022 Apr; 14(4):e23858. PubMed ID: 35530884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.